Barclays upgraded Synovus to Overweight from Equal Weight with a price target of $46, up from $39. The firm says “now is the time to re-engage” shares given the bank’s focus on building capital and improving its earnings run rate. The work Synovus started last June to strengthen its capital and earnings is mostly complete, the analyst tells investors in a research note. Given these moves and the anticipated benefit to net interest income from the securities reinvestment, Barclays increased estimates and upgraded the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV: